Oculus (OCLS) Issued U.S. Patent for Microcyn Tech in Skin Ulcer Treatment
Go back to Oculus (OCLS) Issued U.S. Patent for Microcyn Tech in Skin Ulcer Treatment| OCULUS INNOV SCI (NASDAQ: OCLS) | Delayed: 4.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.95 | 52 Week High | $5.65 | |||
| Open | $1.53 | 52 Week Low | $0.78 | |||
| Day High | $4.95 | P/E | N/A | |||
| Day Low | $4.95 | EPS | $-1.02 | |||
| Volume | 7,700 | |||||
